{
    "clinical_study": {
        "@rank": "109152", 
        "arm_group": {
            "arm_group_label": "Miglustat", 
            "arm_group_type": "Experimental", 
            "description": "miglustat 200mg tid"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the changes in cognitive function after miglustat treatment in Niemann-Pick type\n      C patients."
        }, 
        "brief_title": "Application of Miglustat in Patients With Niemann-Pick Type C", 
        "completion_date": {
            "#text": "December 2010", 
            "@type": "Actual"
        }, 
        "condition": "Niemann-Pick Disease Type C", 
        "condition_browse": {
            "mesh_term": [
                "Niemann-Pick Diseases", 
                "Niemann-Pick Disease, Type A", 
                "Niemann-Pick Disease, Type C", 
                "Aphasia, Primary Progressive", 
                "Pick Disease of the Brain", 
                "Frontotemporal Dementia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with Niemann-Pick C disease will be treated with Miglutat 200mg tid. Neurologic\n      evaluation and safety will be monitored periodically."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Confirm diagnosis of Niemann-Pick C disease\n\n          -  Symptomatic including motor or mental symptoms\n\n        Exclusion Criteria:\n\n          -  Unknown severe diarrhea for more than 7 day\n\n          -  Allergy to miglustat"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "5", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01760564", 
            "org_study_id": "200802043M"
        }, 
        "intervention": {
            "arm_group_label": "Miglustat", 
            "description": "miglustat 200mg tid for adult. For children surface area correction will be made. A lower dose may be used initially to decrease side effect.", 
            "intervention_name": "Miglustat", 
            "intervention_type": "Drug", 
            "other_name": "Zavesca"
        }, 
        "intervention_browse": {
            "mesh_term": "Miglustat"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Niemann-Pick disease type C", 
            "miglustat"
        ], 
        "lastchanged_date": "January 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan"
                }, 
                "name": "National Taiwan University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "1", 
        "official_title": "Application of Miglustat in Patients With Niemann-Pick Type C", 
        "overall_official": {
            "affiliation": "National Taiwan University Hospital", 
            "last_name": "Whu-Liang Hwu, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "videofluoroscopic swallowing study (VFSS), or NP-C functional disability rating scale if VFSS can not be performed due to safety issue", 
            "measure": "Swallowing", 
            "safety_issue": "No", 
            "time_frame": "12th month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01760564"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "22476655", 
            "citation": "Chien YH, Peng SF, Yang CC, Lee NC, Tsai LK, Huang AC, Su SC, Tseng CC, Hwu WL. Long-term efficacy of miglustat in paediatric patients with Niemann-Pick disease type C. J Inherit Metab Dis. 2013 Jan;36(1):129-37. doi: 10.1007/s10545-012-9479-9. Epub 2012 Apr 5."
        }, 
        "secondary_outcome": {
            "description": "IQ test or Mini-Mental Status Examination if a full IQ test can not be performed", 
            "measure": "Mental", 
            "safety_issue": "No", 
            "time_frame": "12th month"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}